Vinorelbine in Unresectable or Metastatic Esophageal and Gastric Adenocarcinoma

NCT00215462 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Cancer
Gastric Cancer
Stomach Cancer

Interventions

DRUG: Vinorelbine

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]
[object Object]
[object Object]